Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000261826 | SCV000406561 | likely benign | Junctional epidermolysis bullosa with pyloric atresia | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Labcorp Genetics |
RCV000950475 | SCV001096786 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000950475 | SCV001151420 | likely benign | not provided | 2020-02-01 | criteria provided, single submitter | clinical testing | |
Johns Hopkins Genomics, |
RCV000261826 | SCV001438380 | benign | Junctional epidermolysis bullosa with pyloric atresia | 2020-09-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000950475 | SCV001820560 | likely benign | not provided | 2020-09-18 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29526452) |
Breakthrough Genomics, |
RCV000950475 | SCV005214089 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Sydney Genome Diagnostics, |
RCV001328148 | SCV001449345 | uncertain significance | Nephrotic syndrome | 2018-10-24 | no assertion criteria provided | clinical testing | This patient is heterozygous for a variant of unknown clinical significance (VOUS), c.2929C>T (p.Arg977Cys), in the ITGB4 gene. To our knowledge, this variant has not been previously reported in the literature to be associated with disease. It has been listed in Exome Aggregation Consortium (ExAC) with a frequency of 335 out of 117600 alleles (0.2%). p.Arg977, is a highly conserved amino acid (up to 11 species) and there is also a large physicochemical difference between the wild type arginine and mutant cysteine. In silico analysis (Alamut Visual v2.6) using Align GVGD, PolyPhen2, SIFT and Mutation Taster all suggest that this variant is likely to be pathogenic. |
Genome Diagnostics Laboratory, |
RCV001729538 | SCV001977865 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000950475 | SCV001978568 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Narges Medical Genetic and Prenatal Diagnosis Lab | RCV003327395 | SCV004035005 | benign | Epidermolysis bullosa, junctional 5A, intermediate | no assertion criteria provided | clinical testing |